Grade My Investments

Sanofi (SNY) Stock Grade

SNY · Healthcare

A+
Grade updated: August 16, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$105.0B
P/E Ratio
12.9
Revenue Growth (YoY)
+5.5%
Net Margin
16.7%
Return on Equity
10.9%
Dividend Yield
5.7%

About Sanofi's fundamentals

Sanofi is a large-cap pharmaceutical company with a market capitalization of $105.0 billion that generates revenue growth of 5.5% year-over-year and maintains a healthy net profit margin of 16.7%. The company trades at a P/E ratio of 12.9 and produces a return on equity of 10.9%, indicating moderate profitability relative to shareholder capital. With a dividend yield of 5.7%, Sanofi returns a meaningful portion of earnings to shareholders, which is relatively high compared to many peers in the pharmaceutical sector.

Track SNY free — no credit card required. Live grade + monthly AI report →